What is the typical duration of gamma‑hydroxybutyrate (GHB) withdrawal?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Duration of GHB Withdrawal

GHB withdrawal typically lasts 5-15 days, with symptoms beginning rapidly within 1-6 hours after the last dose and resolving completely within approximately 3-21 days depending on severity. 1, 2

Timeline and Clinical Course

Onset

  • Rapid onset: Withdrawal symptoms begin 1-6 hours after the last GHB dose 2
  • This is notably faster than most sedative-hypnotic withdrawal syndromes due to GHB's short half-life (20-60 minutes) 1

Acute Phase Duration

The acute withdrawal phase varies by severity:

  • Mild to moderate cases: Symptoms resolve in 3-12 days 3
  • Severe cases: Symptoms persist for 5-15 days 2
  • Most severe/complicated cases: Can extend up to 21 days 1

Symptom Progression

The withdrawal follows a characteristic pattern:

  • Initial symptoms (hours 1-6): Anxiety, insomnia, tremor 2
  • Peak severity (days 1-3): Severe delirium, autonomic instability, hallucinations, agitation requiring physical restraint 2
  • Resolution phase: Symptoms become episodic as the syndrome wanes 2

Clinical Features to Monitor

The withdrawal syndrome is characterized by:

  • Neuropsychiatric: Auditory and visual hallucinations (63%), severe psychosis, delirium, insomnia (58%), confusion 1, 2
  • Autonomic: Tremor (67%), tachycardia (63%), hypertension, diaphoresis 1, 4
  • Complications: Seizures (7%), rhabdomyolysis (7%) 4

Important Clinical Caveats

Severity correlates with use pattern: Patients who develop severe withdrawal typically used GHB every 1-3 hours around-the-clock, indicating heavy physiologic dependence 2. This frequent dosing pattern should raise concern for a more protracted withdrawal course.

Rapid progression risk: GHB withdrawal can escalate quickly from mild anxiety and tremor to life-threatening delirium with autonomic instability within hours 2. This necessitates close monitoring, particularly in the first 24-48 hours.

One documented death occurred on hospital day 13 as withdrawal symptoms were resolving, highlighting that complications can occur even late in the course 2.

Treatment Implications

Benzodiazepines are the treatment of choice, with barbiturates, baclofen, or propofol as second-line options 1. Given the 5-21 day duration, patients require:

  • Inpatient monitoring for severe cases
  • Adequate benzodiazepine dosing (often requiring high doses due to cross-tolerance)
  • Extended observation period beyond typical alcohol withdrawal protocols
  • Monitoring for complications including seizures and rhabdomyolysis

The protracted nature of GHB withdrawal distinguishes it from the acute intoxication effects (which last only 3-6 hours) 5 and requires sustained clinical vigilance throughout the entire withdrawal period.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.